Target Information
INVL Group has successfully concluded the initial closing of its second-generation private equity vehicle, the INVL Private Equity Fund II, raising €305 million. This amount exceeds the initial target of €250 million, establishing the fund as the largest private equity fund in the Baltic region. The fund's investment strategy is focused on countries including Lithuania, Latvia, Estonia, Poland, Romania, and the broader European Union. It aims to target companies that display strong growth potential.
Morphosis Capital has also launched its second fund, the Morphosis Capital Fund II, which has secured over €100 million in committed capital, effectively doubling the size of its previous fund. Based in Romania, this private equity firm intends to focus its investments on small and medium enterprises (SMEs) across Romania and surrounding regions, with particular attention to sectors such as healthcare, B2B services, consumer products, retail, and niche manufacturing.
Industry Overview in Romania
Romania’s private equity landscape has experienced significant growth in recent years, driven by increasing investor interest and a favorable business environment. The government has implemented reforms aimed at streamlining regulations and encouraging foreign investments, making it an attractive destination for private equity firms. Romanian SMEs are particularly appealing due to their potential for expansion and the overall improving economic climate.
The healthcare sector in Romania, where companies like Morphosis Capital are focusing their investments, is witnessing robust growth. Rising consumer demand for quality healthcare services combined with the ongoing digital transformation presents numerous opportunities for private equity investment. This sector benefits from governmental support, as health infrastructure continues to evolve.
Furthermore, the manufacturing sector in Romania has shown resilience, with many companies adapting to increased demand for innovative and niche products. The rise of tech-driven enterprises within this segment aligns with global trends, creating a dynamic investment environment that appeals to private equity investors seeking long-term returns.
Lastly, the retail and consumer products industries in Romania are also surging, fueled by a growing middle class and increased disposable income. As consumer preferences shift towards modern retail solutions, private equity firms are keen to invest in businesses that effectively cater to these emerging trends.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The rationale for INVL Group's fundraising initiative lies in the increasing demand for private equity investment in the Baltic region, aimed at elevating the growth potential of budding companies. By establishing the INVL Private Equity Fund II, the firm positions itself to leverage the opportunities present in underserved markets across Central and Eastern Europe.
Similarly, Morphosis Capital's second fund launch is driven by the firm’s commitment to capitalize on the growth trajectory of Romanian SMEs. The fund's increased capital allows for larger investments, enabling diversification and the pursuit of more significant stakes in promising companies within critical sectors.
Investor Information
INVL Group is a recognized player in the Baltic private equity market, with a proven track record in managing assets and generating significant returns for its investors. Their expertise in identifying and nurturing high-potential investments positions them well to maximize performance through strategic partnerships and operational enhancements across portfolio companies.
Morphosis Capital, known for its focus on the Romanian market, continues to build its reputation by supporting SMEs in their growth journeys. Their commitment to developing the local ecosystem is evident through their targeted investment strategies, which aim to enhance value and drive sustainable business growth.
View of Dealert
The establishment of INVL Private Equity Fund II is a promising indicator of the Baltic region’s growing appeal among investors. The combination of substantial capital raised and a clear strategy to target high-growth potential companies suggests a strong likelihood of success. The fund’s diversified geographic and sectoral approach positions it well to take advantage of emerging opportunities across the EU, thus enhancing its long-term value proposition.
Morphosis Capital's second fund also appears to be a strategic move in an evolving market, especially with its firm focus on SMEs. The fund's emphasis on sectors like healthcare and niche manufacturing aligns with global demand trends, suggesting that it may present substantial growth opportunities and strong returns on investment.
Overall, the current landscape in the Baltic and Romanian markets signals favorable conditions for private equity investments. The array of opportunities available indicates that these funds are well-positioned not only to achieve their investment goals but also to contribute positively to the economic development of their respective regions.
Similar Deals
INVL Private Equity Fund II, IFC, Accession Capital Partners → POLMED
2025
Enterprise Investors → NZOZ Śródmieście-Biały Kamień
2024
Karo Healthcare → Perrigo’s Dermacosmetics portfolio
2026
ChristianaCare → Crozer Health outpatient locations
2025
HCAP Partners → First Choice Mobile Radiology Services, LLC
2025
Prime Healthcare → Ascension facilities
2025
Bain Capital → HealthEdge and UST HealthProof
2025
KKR → Henry Schein
2025
MidEuropa
invested in
Diagnostyka
in 2025
in a Other Private Equity deal
Disclosed details
Transaction Size: $441M
Revenue: $1M
EBITDA: $1M
EBIT: $1M
Net Income: $1M
Enterprise Value: $1M
Equity Value: $1M
Multiples
EV/EBITDA: 1.0x
EV/EBIT: 1.0x
EV/Revenue: 1.0x
P/E: 1.0x
P/Revenue: 1.0x